Post-transplantation cyclophosphamide and cyclosporine A versus methotrexate and cyclosporine A for graft-versus-host disease prophylaxis after allogeneic peripheral stem cell transplantation in adult acute myeloid leukemia patients-Reference-Cited by-同舟云学术

Post-transplantation cyclophosphamide and cyclosporine A versus methotrexate and cyclosporine A for graft-versus-host disease prophylaxis after allogeneic peripheral stem cell transplantation in adult acute myeloid leukemia patients

Published:2024-10 Issue: Volume:491 Page:117071
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Sharaf El-Deen Mustafa O.,Soliman Moetaza M.,Al-Azab Gamal,Samra Mohamed,Shams Mohammad E.E.

Publisher

Elsevier BV

Reference29 articles.

1. Phase II trial of graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide after reduced-intensity Busulfan/Fludarabine conditioning for hematological malignancies;Alousi;Biol. Blood Marrow Transpl.,2015

2. Impact of chronic graft-versus-host disease on late relapse and survival on 7,489 patients after Myeloablative allogeneic hematopoietic cell transplantation for leukemia;Boyiadzis;Clin. Cancer Res.,2015

3. Single-agent high-dose cyclophosphamide for graft-versus-host disease prophylaxis in human leukocyte antigen-matched reduced-intensity peripheral blood stem cell transplantation results in an unacceptably high rate of severe acute graft-versus-host disease;Bradstock;Biol. Blood Marrow Transpl.,2015

4. Post-transplant cyclophosphamide and tacrolimus-mycophenolate Mofetil combination prevents graft-versus-host disease in allogeneic peripheral blood hematopoietic cell transplantation from HLA-matched donors;Carnevale-Schianca;Biol. Blood Marrow Transpl.,2017

5. Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label, randomized controlled study;Chang;J. Clin. Oncol.,2020